ArticlePloS one2015

Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis.

Francesca Pierotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.